1. U.S. Food and Drug Administration (FDA). Step 3: Clinical research. The drug development process. Available at: https://www.fda.gov/patients/drug-development-process/step-3-clinical-research. Accessed June 2, 2021.
2. MCPMod: An R package for the design and analysis of dose-finding studies;Bornkamp;J Stat Soft,2009
3. Efficiencies of platform clinical trials: A vision of the future;Saville;Clin Trials,2016
4. U.S. Food and Drug Administration (FDA). 22 case studies where phase 2 and phase 3 trials had divergent results, 2017. Available at: https://www.fda.gov/about-fda/reports/22-case-studies-where-phase-2-and-phase-3-trials-had-divergent-results. Accessed June 2, 2021.
5. Design considerations for dose-expansion cohorts in phase I trials;Iasonos;JCO,2013